Tumor Biology

, Volume 35, Issue 6, pp 5453–5457 | Cite as

Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population

  • Chengli Liu
  • Yingjie Wang
  • Hui Huang
  • Cheng Wang
  • Hui Zhang
  • Yalin Kong
  • Hongyi Zhang
Research Article


Pancreatic cancer is one of the human cancers with the highest fatality rates; however, the etiology still remains largely unknown. Recently, one genome-wide association study (GWAS), conducted exclusively among women of European ancestry, has discovered that cleft lip and palate transmembrane 1-like telomerase reverse transcriptase (CLPTM1L-TERT) rs401681 polymorphism was significantly associated with pancreatic cancer risk. Few studies have been conducted to evaluate whether this finding could be generalized to Chinese people. In the current study, we explored the association between rs401681 polymorphism and risk of pancreatic cancer in a case–control study of 1,587 Chinese people (including 766 pancreatic cancer cases and 821 healthy controls). Under the log-additive model, each additional copy of minor allele T was associated with a 1.24-fold increased risk of pancreatic cancer (odds ratio (OR) = 1.24, 95 % confidence interval (CI) 1.06–1.44, P = 5.61 × 10−3). While compared with individuals with the CC genotype, the OR for developing pancreatic cancer was 1.09 (95 % CI 0.88–1.34) among those with the CT genotype and 1.66 (95 % CI 1.20–2.29) among those with the TT genotype. Additional adjustments for the confounding factors did not change the results materially. Our data suggests that the T allele of rs401681 in CLPTM1L-TERT locus predisposes its carriers to pancreatic cancer, and further research into the function of CLPTM1L-TERT locus and its potential biological mechanism association may be warranted.


Pancreatic cancer CLPTM1L-TERT SNP Genetic susceptibility 



We thank all staff who were involved in the subject recruitment, telephone interviews, sample preparation, and laboratory assays for their hard works.

Conflicts of interest



  1. 1.
    Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607–20.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–17.CrossRefPubMedGoogle Scholar
  3. 3.
    Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen H, Zhou B, Lan X, Wei D, Yuan T, Chen P. Association between single-nucleotide polymorphisms of OGG1 gene and pancreatic cancer risk in Chinese Han population. Tumour Biol 2013.Google Scholar
  5. 5.
    Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166–76.CrossRefPubMedGoogle Scholar
  6. 6.
    Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986–90.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224–8.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Diergaarde B, Brand R, Lamb J, Cheong SY, Stello K, Barmada MM, et al. Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology. 2010;10:194–200.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, Kurtz RC, et al. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res. 2012;18:3942–51.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Ma X, Zhang B, Zheng W. Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut 2013.Google Scholar
  11. 11.
    Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 2012;44:62–6.CrossRefGoogle Scholar
  12. 12.
    Lokody I. Biomarkers: TERT marks recurrence of urothelial cancer. Nat Rev Cancer. 2013;14:11.Google Scholar
  13. 13.
    Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P. Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. Int J Cancer 2013.Google Scholar
  14. 14.
    Genetics: TERT mutation in urogenital cancers. Nature Reviews Urology 2013.Google Scholar
  15. 15.
    Eldholm V, Haugen A, Zienolddiny S. CTCF mediates the TERT enhancer–promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene. Int J Cancer 2013.Google Scholar
  16. 16.
    Bladder cancer: TERT mutations as urine biomarkers of neoplasia. Nature Reviews Urology 2013;10:677.Google Scholar
  17. 17.
    Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41:221–7.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Liu Z, Li G, Wei S, Niu J, Wang LE, Sturgis EM, et al. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010;31:1977–81.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun. 2001;280:1148–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 1997;17:498–502.CrossRefPubMedGoogle Scholar
  21. 21.
    Sundin T, Hentosh P. InTERTesting association between telomerase, mTOR and phytochemicals. Expert Rev Mol Med. 2012;14:e8.CrossRefPubMedGoogle Scholar
  22. 22.
    Izzo G, Freitas EL, Krepischi AC, Pearson PL, Vasques LR, Passos-Bueno MR, et al. A microduplication of 5p15.33 reveals CLPTM1L as a candidate gene for cleft lip and palate. Eur J Med Genet. 2013;56:222–5.CrossRefPubMedGoogle Scholar
  23. 23.
    James MA, Vikis HG, Tate E, Rymaszewski AL, You M. CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. Cancer Res 2013.Google Scholar
  24. 24.
    Lan Q, Cawthon R, Gao Y, Hu W, Hosgood 3rd HD, Barone-Adesi F, et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One. 2013;8:e59230.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Li C, Yin Z, Wu W, Li X, Ren Y, Zhou B. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in Chinese women nonsmokers. PLoS One. 2013;8:e64988.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Li C, Yin Z, Wu W, Li X, Zhou B. Genetic variants in TERT-CLPTM1L genetic region associated with several types of cancer: a meta-analysis. Gene. 2013;526:390–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Myneni AA, Chang SC, Niu R, Liu L, Ochs-Balcom HM, Li Y, et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer—a case–control study in a Chinese population. Lung Cancer. 2013;80:131–7.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Schilling G, Penas EM, Janjetovic S, Oliveira-Ferrer L, Braig M, Behrmann P, et al. Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus. Leuk Res. 2013;37:280–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Yang X, Yang B, Li B, Liu Y. Association between TERT-CLPTM1L rs401681[c] allele and NMSC cancer risk: a meta-analysis including 45,184 subjects. Arch Dermatol Res. 2013;305:49–52.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhao Z, Li C, Yang L, Zhang X, Zhao X, Song X, et al. Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population. Exp Lung Res. 2013;39:91–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhong R, Liu L, Zou L, Zhu Y, Chen W, Zhu B, et al. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Mol Carcinog. 2013;52 Suppl 1:E118–26.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Chengli Liu
    • 1
  • Yingjie Wang
    • 2
  • Hui Huang
    • 3
  • Cheng Wang
    • 1
  • Hui Zhang
    • 1
  • Yalin Kong
    • 1
  • Hongyi Zhang
    • 1
  1. 1.Department of Hepatobiliary SurgeryAir Force General Hospital of PLABeijingChina
  2. 2.Department of Radiation OncologyAir Force General Hospital of PLABeijingChina
  3. 3.Department of Hepatobiliary Surgery309 Hospital of PLABeijingChina

Personalised recommendations